Related Experiment Videos
[Atrial natriuretic factor in cardiovascular pathology]
1Service de Biochemie médicale, CHU Pitié-Salpêtrière, Paris.
Insights
Atrial natriuretic factor (ANF), a hormone released by the heart, plays a key role in cardiovascular regulation. Its detection revealed a new hormonal system, highlighting the heart
Area of Science:
- Cardiology
- Endocrinology
- Physiology
Context:
- The heart functions as an endocrine gland, producing atrial natriuretic factor (ANF).
- ANF release is primarily stimulated by atrial distension.
- ANF is integral to the newly discovered natriuretic vasomotor relaxant hormonal system.
Purpose:
- To elucidate the role of atrial natriuretic factor (ANF) in cardiovascular physiology and pathophysiology.
- To highlight ANF's implications in cardiovascular disorders, particularly congestive heart failure.
Summary:
- Atrial natriuretic factor (ANF) is a cardiac hormone with significant cardiovascular effects, including hypotension and reduced cardiac output.
- Plasma ANF concentration serves as an indicator of disease severity in conditions like congestive heart failure.
- Hemodynamic changes from valvular heart disease and dysrhythmias influence ANF release.
Impact:
- ANF's discovery redefined understanding of the heart's endocrine function.
- ANF is recognized as a critical factor in the pathophysiology of diverse cardiovascular disorders.
- ANF levels provide valuable insights into hemodynamic status and disease progression in heart conditions.
Abstract:
Atrial natriuretic factor (ANF) is a cardiac peptide hormone whose detection led to the discovery of a new natriuretic vasomotor relaxant hormonal system where the heart plays the role of an endocrine gland. Atrial distension represents the main stimulus for the release of ANF. Its cardiovascular effects consist primarily of hypotension related to its relaxant properties, a decrease in cardiac output and a negative inotropic effect. The close relations between ANF and the heart implicate this hormone as a major factor in all cardiovascular disorders, and in particular in congestive heart failure where its plasma concentration represents an index of hemodynamic and functional disease severity. Hemodynamic changes related to valvular heart disease, whether of the mitral or aortic valve, as well as dysrhythmias have a significant effect on release of ANF. Thus, it is now well recognized that ANF, released by the heart, is implicated in the pathophysiology of cardiovascular disorders.